1. No category

First Joint Meeting
of the European Society of Cardiology
Council on Hypertension
and
Working Group on peripheral
Circulation
October 24–25, 2014
Prague, Czech Republic
www.pragueheart2014.com
First Joint Meeting of the European Society of Cardiology
First Joint Meeting of the European Society of Cardiology
Council on Hypertension and
Working Group on peripheral Circulation
Council on Hypertension and
Working Group on peripheral Circulation
SCIENTIFIC COMMITTEE - COUNCIL ON HYPERTENSION
Chairperson: Renata Cífková, Prague, CZ
Members: Jana Brguljan, Ljubljana, SLO • Antonio Coca, Barcelona, ES,
Serap Erdine, Istanbul, TR • Anthony Heagerty, Manchester, GB,
Thomas Kahan, Stockholm, SE • Dragan Lovic, Nis, RS,
Athanasios Manolis, Athens, GR • Jean-Jacques Mourad, Bobigny, FR,
Gianfranco Parati, Milan, IT • Costas Tsioufis, Athens, GR,
Philippe van de Borne, Brussels, BE • Massimo Volpe, Rome, IT
FINAL PROGRAM
October 24-25, 2014 • Prague, Czech Republic
OCTOBER 24 (FRIDAY)
09:00 - 09:05
Opening
R. Cífková (Prague, CZ)
Introductory session
Chairpersons: A. Coca (Barcelona, ES), C. Vlachopoulos (Athens, GR)
SCIENTIFIC COMMITTEE - WG PERIPHERAL CIRCULATION
Chairpersons: Charalambos Vlachopoulos, Athens, GR • Marianne Brodmann, Graz, AT
Members: Victor Aboyans, Limoges, FR • Francesco Cosentino, Rome, IT,
Marco De Carlo, Pisa, IT • Augusto Franco Gallino, Bellinzona, CH,
John Lekakis, Athens, GR • Dimitri P. Mikhailidis, London, GB,
Katerina Naka, Ioannina, GR • Damiano Rizzoni, Brescia, IT,
Thomas Weber, Wels, AT • Panagiotis Xaplanteris, Athens, GR
Reuven Zimlichman, Tel Aviv, IL
ORGANIZING AGENCY
09:05 - 09:30
Vascular aging in hypertension
09:30 - 09:55
Hypertension: a vascular disease?
09:55 - 10:20 Hypertension and dementia
10:20 - 10:45
The future of antihypertensive therapy
10:45 - 11:15 Coffee break
C. Vlachopoulos (Athens, GR)
D. Clement (Gent, BE)
A. Coca (Barcelona, ES)
G. Mancia (Milan, IT)
Risk stratification and blood pressure measurement
Chairpersons: D. Clement (Gent, BE), G. Stergiou (Athens, GR)
GALÉN-SYMPOSION, s.r.o.
Břežanská 10
100 00 - Prague 10
Czech Republic
11:15 - 11:40
M. Dorobantu (Bucharest, RO)
11:40 - 13:00
Blood pressure measurement
Email:h.stredova@gsymposion.cz
j.krusina@gsymposion.cz
Phone: +420 222 518 535
3 T. Kahan (Stockholm, SE)
2. Home blood pressure: from research to clinical practice
3. Ambulatory blood pressure monitoring: indications and practical
considerations
MEETING VENUE
DIPLOMAT HOTEL PRAGUE ****
Evropská 15, 160 00 Prague, Czech Republic
www.diplomathotel.cz
Risk stratification in hypertension
1. What is the standard of office blood pressure in 2015?
G. Stergiou (Athens, GR)
G. Bilo (Milan, IT)
4. White-coat hypertension and masked hypertension:
evaluation and prognostic implications
G. Mancia (Milan, IT)
13:00 - 14:00
Lunch
First Joint Meeting of the European Society of Cardiology
First Joint Meeting of the European Society of Cardiology
Council on Hypertension and
Working Group on peripheral Circulation
Council on Hypertension and
Working Group on peripheral Circulation
14:00 - 15:00
Scientific session sponsored by Servier
Chairpersons: G. Mancia (Milan, IT), R. Cífková (Prague, CZ)
14:00 - 15:00
A novel concept in hypertension: triple combination
1. Why is hypertension still poorly controlled and who may benefit from
a triple combination
R. Cífková (Prague, CZ)
2. What is the rationale for combining ACE inhibitors,
calcium-channels blockers, and diuretics
S. Laurent (Paris, FR)
3. Clinical evidence for triple combination in hypertension
OCTOBER 25 (SATURDAY)
08:30 - 10:10
Hypertension and comorbidities
Chairpersons: P. Nilsson (Malmoe, SE), R. Hatala (Bratislava, SK)
1. Hypertension and diabetes
2. Hypertension and coronary heart disease
3. Hypertension and atrial fibrillation
P. Nilsson (Malmoe, SE)
T. Kahan (Stockholm, SE)
R. Hatala (Bratislava, SK)
G. Mancia (Milan, IT)
15:00 - 16:00
Vascular biomarkers in hypertension
Chairperson: M. Brodmann (Graz, AT)
3 M. Burnier (Lausanne, CH)
10:10 - 10:40 Coffee break
1. Pulse wave velocity
2. Ankle-brachial index
3. Carotid ultrasound
I. Ikonomidis (Athens, GR)
V. Aboyans (Limoges, FR)
A. Schmidt-Trucksäss (Basel, CH)
16:00 - 16:15Discussion
16:15 - 16:20
Concluding remarks
C. Vlachopoulos (Athens, GR), R. Cífková (Prague, CZ)
16:20 - 17:00 Coffee break
A moderated poster guided tour will be organized during the coffee break
Posters 1–5
Discussant: P. van de Borne (Brussels, BE)
17:00 - 18:20
Reference values for arterial parameters: how to use them
Chairperson: S. Laurent (Paris, FR)
1. Reference values for aortic stiffness
2. R
eference values for carotid atherosclerosis and carotid stiffness
3. Reference values for central BP
L. Van Bortel (Gent, BE)
I. Ferreira (Maastricht, NL)
P. Boutouyrie (Paris, FR)
4. Hypertension and chronic kidney disease
A moderated poster guided tour will be organized during the coffee break
Posters 6–11
Discussant: K. Narkiewicz (Gdansk, PL)
10:40 - 11:20
Perioperative management of hypertension
Chairpersons: D. Lovic (Nis, RS), B. Jelakovic (Zagreb, HR)
1. Diagnostic work-up and assessment
2. Management
J. Brguljan (Ljubljana, SI)
P. van de Borne (Brussels, BE)
11:20 - 13:00
Resistant hypertension
Chairpersons: T. Kahan (Stockholm, SE), T. Schmitz (Essen, DE)
1. Definition and epidemiology of resistant hypertension
2. Assessment of a patient referred for resistant hypertension
3. Compliance as a critical issue
4. Sympathetic nervous system in resistant hypertension
5. Renal denervation – introduction of the technique
and a critical review of results
his session was partly supported by an unrestricted grant
T
from St. Jude Medical
13:00 - 14:00 Lunch
S. Erdine (Istanbul, TR)
T. Kahan (Stockholm, SE)
M. Burnier (Lausanne, CH)
K. Narkiewicz (Gdansk, PL)
T. Schmitz (Essen, DE)
First Joint Meeting of the European Society of Cardiology
First Joint Meeting of the European Society of Cardiology
Council on Hypertension and
Working Group on peripheral Circulation
Council on Hypertension and
Working Group on peripheral Circulation
14:00 - 15:00
Abstract session
Chairpersons: S. Erdine (Istanbul, TR), J. Brguljan (Ljubljana, SI)
1. Coronary artery disease severity and cardiovascular risk factors
2. Prevalence of hypertension and diabetes mellitus in patients with
ischemic heart disease – a comparative analysis between Indian and
Bulgarian population
O
. Hamza, A. Azzouz, O. Ait Mokhtar, N. Bendaoud, M. Saidane, A. Sik, S. Latriche, K. Merad, S. Benkhedda (Algiers, DZ)
C
. James, T. Attacheril, S. Jose, K. Gospodinov, S. Tisheva, D. Yakova,
M. Hristov, N. Stancheva (Pleven, BG)
3. New predictors of CV risk in hypertensive patients
3 O. Tăutu, R. Darabont, S. Onciul, A. Deaconu, I. Petre, R. D. Andrei,
3 B. Drăgoescu, M. Dorobantu (Bucharest, RO)
4. The prognostic role of inflammatory biomarkers, D-dimer and mean
platelet volume in hypertensive patients with type A acute aortic
dissection
M. Vrsalovic (Zagreb, HR)
5. Antihypertensive drug therapy in Sweden in relation to gender, age,
and comorbidity
F. Wallentin, B. Wettermark, T. Kahan (Stockholm, SE)
6. Predictors of increased arterial stiffness in hypertensive patients
O. Tăutu, R. Darabont, S. Onciul, A. Deaconu, I. Petre, R. D. Andrei, B. Drăgoescu, M. Dorobantu (Bucharest, RO)
15:00 - 16:30
“How to” session
Chairpersons: S. Laurent (Paris, FR), A. Linhart (Prague, CZ)
1. How to evaluate left ventricular hypertrophy
2. How to assess carotid ultrasound
3. How to assess pulse wave velocity
16:30
Closure
E. Gerdts (Bergen, NO)
A. Linhart (Prague, CZ)
S. Laurent (Paris, FR)
POSTERS
1.The cardioprotective potential of bosentan in myocardial ischemia/reperfusion:
A concept of anti-inflammatory and antioxidant approaches
N. R. Hadi, F. G. Al-Amran, Y. Ali (Kufa, IQ)
2.Zofenopril protects from myocardial ischemia/reperfusion via interferring
with inflammatory response and apoptosis
N. R. Hadi, F. G. Al-Amran, Y. Ali (Kufa, IQ)
3. Tobacco use and some characteristics of tobacco users: preliminary results
of Kardiovize 2030
O
. Sochor, E. Kralikova, R. Cifkova, J. Fiala, I. Tomaskova, R. Stepanova, J. Vitovec,
T. Kara, P. Wohlfahrt, F. Lopez-Jimenez (Brno and Prague, CZ; Rochester, MN, USA)
4.Evaluation of clinical efficacy of amlodipine and indapamide combination
in hypertensive patients
G. A. Khamidullaeva, N. S. Shakirova, N. Z. Srojidinova (Tashkent, UZ)
5. Influence of three monthly combined therapy with indapamide and lercanidipine
on target organ damage in dependence of salt sensitivity in hypertensive patients
L. S. Khafisova, G. A. Khamidullaeva, G. J. Abdullaeva (Tashkent, UZ)
6.The influence of anthracycline antibiotics on cardiovascular system and renal
hemodynamics of patients with lymphoproliferative disease
A. M. Svanadze, N. G. Poteshkina, N. S. Krylova, N. M. Chkhaidze (Moscow, RU)
7.Improved treatment and control of hypertension in Swedish primary care:
results from the Swedish Primary Care Cardiovascular Database (SPCCD)
C
. Holmquist, J. Hasselström, K. Bengtsson Boström, P. Hjerpe, K. Manhem, T. Kahan
(Stockholm, SE)
8.Improved endothelial function during normal pregnancy
C. Iacobaeus, M. Thorsell, E. Andolf, K. Bremme, T. Kahan (Stockholm, SE)
9.Cardiovascular hemodynamics as complications predictor in pregnancy
N. Božič, A. Pliberšek, N. Ovsenik, P. Dolenc, R. Accetto, B. Salobir, J. Brguljan-Hitij
(Ljubljana, SI)
10. Prevalence of obesity in Brno, results of the Kardiovize BRNO 2030 Study
R. Prosecky, O. Sochor, M. Homolka, P. Kruzlik, R. Cífková (Brno and Prague, CZ)
11. Prognostic significance of dipping in older hypertensive patients
M. Bendzala, L. Gaspar (Bratislava, SK)
Supported by an unrestricted educational
grant from Servier
www.pragueheart2014.com